Table S2 from Evaluating Serum Thymidine Kinase 1 in Patients with Hormone Receptor–Positive Metastatic Breast Cancer Receiving First-line Endocrine Therapy in the SWOG S0226 Trial
Year: 2023
Type: other
Abstract: Supplementary Table 2. Multivariable Model of sTKI after Adjustment for Treatment, Age, and Disease Characteristics.
Language: English
Subfield: Cancer Research
Domain: Life Sciences
Open Access status: gold
OpenAlex ID: W4361815050
